Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in cutaneous or indolent systemic mastocytosis
NCT05084872Phase 3Unknown
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Oct 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in cutaneous mastocytosis (CM), indolent systemic mastocytosis (ISM), sponsored by Centre hospitalier universitaire de Toulouse. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
cutaneous mastocytosis (CM)indolent systemic mastocytosis (ISM)
Beyond the preview
Go deeper on NCT05084872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05084872.